Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells

MLA

Rebecca S. Cook, et al. “Receptor Tyrosine Kinase ERBB4 Mediates Acquired Resistance to ERBB2 Inhibitors in Breast Cancer Cells.” Cell Cycle, vol. 14, Feb. 2015, pp. 648–55. EBSCOhost, https://doi.org/10.4161/15384101.2014.994966.

APA

Rebecca S. Cook, Andres Buonanno, Charlotte R. Williams, Meghan M. Morrison, Huizhong Hu, Matthew Ung, Rachel Schiff, Manabu Kurokawa, Owen M. Wilkins, Wendy A. Wells, Karen T. Liby, Detlef Vullhorst, Kaleigh Canfield, & Jiaqi Li. (2015). Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells. Cell Cycle, 14, 648–655. https://doi.org/10.4161/15384101.2014.994966

Chicago

Rebecca S. Cook, Andres Buonanno, Charlotte R. Williams, Meghan M. Morrison, Huizhong Hu, Matthew Ung, Rachel Schiff, et al. 2015. “Receptor Tyrosine Kinase ERBB4 Mediates Acquired Resistance to ERBB2 Inhibitors in Breast Cancer Cells.” Cell Cycle 14 (February): 648–55. doi:10.4161/15384101.2014.994966.